Literature DB >> 18364470

The human multidrug resistance protein 4 (MRP4, ABCC4): functional analysis of a highly polymorphic gene.

Nada Abla1, Leslie W Chinn, Tsutomu Nakamura, Li Liu, Conrad C Huang, Susan J Johns, Michiko Kawamoto, Doug Stryke, Travis R Taylor, Thomas E Ferrin, Kathleen M Giacomini, Deanna L Kroetz.   

Abstract

ABCC4 encodes multidrug resistance protein 4 (MRP4), a member of the ATP-binding cassette family of membrane transporters involved in the efflux of endogenous and xenobiotic molecules. The aims of this study were to identify single nucleotide polymorphisms of ABCC4 and to functionally characterize selected nonsynonymous variants. Resequencing was performed in a large ethnically diverse population. Ten nonsynonymous variants were selected for analysis of transport function based on allele frequencies and evolutionary conservation. The reference and variant MRP4 cDNAs were constructed by site-directed mutagenesis and transiently transfected into human embryonic kidney cells (HEK 293T). The function of MRP4 variants was compared by measuring the intracellular accumulation of two antiviral agents, azidothymidine (AZT) and adefovir (PMEA). A total of 98 variants were identified in the coding and flanking intronic regions of ABCC4. Of these, 43 variants are in the coding region, and 22 are nonsynonymous. In a functional screen of ten variants, there was no evidence for a complete loss of function allele. However, two variants (G187W and G487E) showed a significantly reduced function compared to reference with both substrates, as evidenced by higher intracellular accumulation of AZT and PMEA compared to the reference MRP4 (43 and 69% increase in accumulation for G187W compared with the reference MRP4, with AZT and PMEA, respectively). The G187W variant also showed decreased expression following transient transfection of HEK 293T cells. Further studies are required to assess the clinical significance of this altered function and expression and to evaluate substrate specificity of this functional change.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18364470      PMCID: PMC2612728          DOI: 10.1124/jpet.108.136523

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  41 in total

1.  A new statistical method for haplotype reconstruction from population data.

Authors:  M Stephens; N J Smith; P Donnelly
Journal:  Am J Hum Genet       Date:  2001-03-09       Impact factor: 11.025

2.  Polymorphisms in OATP-C: identification of multiple allelic variants associated with altered transport activity among European- and African-Americans.

Authors:  R G Tirona; B F Leake; G Merino; R B Kim
Journal:  J Biol Chem       Date:  2001-07-26       Impact factor: 5.157

3.  Analysis of methotrexate and folate transport by multidrug resistance protein 4 (ABCC4): MRP4 is a component of the methotrexate efflux system.

Authors:  Zhe-Sheng Chen; Kun Lee; Susan Walther; Rebecca Blanchard Raftogianis; Michihiko Kuwano; Hao Zeng; Gary D Kruh
Journal:  Cancer Res       Date:  2002-06-01       Impact factor: 12.701

4.  Thiopurine metabolism and identification of the thiopurine metabolites transported by MRP4 and MRP5 overexpressed in human embryonic kidney cells.

Authors:  P R Wielinga; G Reid; E E Challa; I van der Heijden; L van Deemter; M de Haas; C Mol; A J Kuil; E Groeneveld; J D Schuetz; C Brouwer; R A De Abreu; J Wijnholds; J H Beijnen; P Borst
Journal:  Mol Pharmacol       Date:  2002-12       Impact factor: 4.436

5.  Variability in human hepatic MRP4 expression: influence of cholestasis and genotype.

Authors:  U Gradhand; T Lang; E Schaeffeler; H Glaeser; H Tegude; K Klein; P Fritz; G Jedlitschky; H K Kroemer; I Bachmakov; B Anwald; R Kerb; U M Zanger; M Eichelbaum; M Schwab; M F Fromm
Journal:  Pharmacogenomics J       Date:  2007-04-03       Impact factor: 3.550

6.  Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogs.

Authors:  J Wijnholds; C A Mol; L van Deemter; M de Haas; G L Scheffer; F Baas; J H Beijnen; R J Scheper; S Hatse; E De Clercq; J Balzarini; P Borst
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

7.  Human organic anion transporters and human organic cation transporters mediate renal antiviral transport.

Authors:  Michio Takeda; Suparat Khamdang; Shinichi Narikawa; Hiroaki Kimura; Yasuna Kobayashi; Toshinori Yamamoto; Seok Ho Cha; Takashi Sekine; Hitoshi Endou
Journal:  J Pharmacol Exp Ther       Date:  2002-03       Impact factor: 4.030

8.  The MRP4/ABCC4 gene encodes a novel apical organic anion transporter in human kidney proximal tubules: putative efflux pump for urinary cAMP and cGMP.

Authors:  Rémon A M H van Aubel; Pascal H E Smeets; Janny G P Peters; René J M Bindels; Frans G M Russel
Journal:  J Am Soc Nephrol       Date:  2002-03       Impact factor: 10.121

9.  Identification of 779 genetic variations in eight genes encoding members of the ATP-binding cassette, subfamily C (ABCC/MRP/CFTR.

Authors:  Susumu Saito; Aritoshi Iida; Akihiro Sekine; Yukie Miura; Chie Ogawa; Saori Kawauchi; Shoko Higuchi; Yusuke Nakamura
Journal:  J Hum Genet       Date:  2002       Impact factor: 3.172

10.  Expression of MRP4 confers resistance to ganciclovir and compromises bystander cell killing.

Authors:  Masashi Adachi; Janardhan Sampath; Lu-bin Lan; Daxi Sun; Philip Hargrove; Robin Flatley; Ann Tatum; Mary Z Edwards; Michele Wezeman; Larry Matherly; Richard Drake; John Schuetz
Journal:  J Biol Chem       Date:  2002-06-24       Impact factor: 5.157

View more
  49 in total

1.  Predictable difficulty or difficulty to predict.

Authors:  Tamás Arányi; Krisztina Fülöp; Orsolya Symmons; Viola Pomozi; András Váradi
Journal:  Protein Sci       Date:  2011-01       Impact factor: 6.725

2.  Functional hot spots in human ATP-binding cassette transporter nucleotide binding domains.

Authors:  Libusha Kelly; Hisayo Fukushima; Rachel Karchin; Jason M Gow; Leslie W Chinn; Ursula Pieper; Mark R Segal; Deanna L Kroetz; Andrej Sali
Journal:  Protein Sci       Date:  2010-11       Impact factor: 6.725

3.  In Vitro Transport Activity and Trafficking of MRP2/ABCC2 Polymorphic Variants.

Authors:  Xia Wen; Melanie S Joy; Lauren M Aleksunes
Journal:  Pharm Res       Date:  2017-04-12       Impact factor: 4.200

Review 4.  Pharmacogenomic discovery using cell-based models.

Authors:  Marleen Welsh; Lara Mangravite; Marisa Wong Medina; Kelan Tantisira; Wei Zhang; R Stephanie Huang; Howard McLeod; M Eileen Dolan
Journal:  Pharmacol Rev       Date:  2009-12       Impact factor: 25.468

Review 5.  Multiple drug resistance-associated protein 4 (MRP4), prostaglandin transporter (PGT), and 15-hydroxyprostaglandin dehydrogenase (15-PGDH) as determinants of PGE2 levels in cancer.

Authors:  Tyler J Kochel; Amy M Fulton
Journal:  Prostaglandins Other Lipid Mediat       Date:  2014-11-27       Impact factor: 3.072

Review 6.  Clioquinol: To harm or heal.

Authors:  Dominique R Perez; Larry A Sklar; Alexandre Chigaev
Journal:  Pharmacol Ther       Date:  2019-03-18       Impact factor: 12.310

7.  Deregulated hepatic metabolism exacerbates impaired testosterone production in Mrp4-deficient mice.

Authors:  Jessica A Morgan; Satish B Cheepala; Yao Wang; Geoff Neale; Masashi Adachi; Deepa Nachagari; Mark Leggas; Wenchen Zhao; Kelli Boyd; Raman Venkataramanan; John D Schuetz
Journal:  J Biol Chem       Date:  2012-02-28       Impact factor: 5.157

8.  MRP4-mediated regulation of intracellular cAMP and cGMP levels in trabecular meshwork cells and homeostasis of intraocular pressure.

Authors:  Padmanabhan P Pattabiraman; Paula E Pecen; Ponugoti Vasantha Rao
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-03-05       Impact factor: 4.799

9.  A pharmacogenetic candidate gene study of tenofovir-associated Fanconi syndrome.

Authors:  Amber Dahlin; Matthias Wittwer; Melanie de la Cruz; Jonathan M Woo; Rujuta Bam; Valeska Scharen-Guivel; John Flaherty; Adrian S Ray; Tomas Cihlar; Samir K Gupta; Kathleen M Giacomini
Journal:  Pharmacogenet Genomics       Date:  2015-02       Impact factor: 2.089

Review 10.  The pharmacogenomics of membrane transporters project: research at the interface of genomics and transporter pharmacology.

Authors:  D L Kroetz; S W Yee; K M Giacomini
Journal:  Clin Pharmacol Ther       Date:  2009-11-25       Impact factor: 6.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.